Ryan K. Flannigan, MD, FRCSC, highlights a phase 2 study of the sustained-release lidocaine formulation ST-01 as a potential nonsurgical treatment for chronic scrotal content pain.
Ryan K. Flannigan, MD, FRCSC
Advertisement
Articles by Ryan K. Flannigan, MD, FRCSC
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: AUA 2026 Update on Prostate Cancer Early Detection, With Badrinath R. Konety, MBBS
2
EV plus pembro approval reframes first conversation in MIBC diagnosis
3
Daniel George, MD, on the significance of the capivasertib approval for PTEN-deficient prostate cancer
4
Ravi Munver, MD, highlights study of first- and second-generation Aquablation systems
5